Filing Details

Accession Number:
0001181431-13-041160
Form Type:
4
Zero Holdings:
No
Publication Time:
2013-07-23 19:10:15
Reporting Period:
2013-07-23
Filing Date:
2013-07-23
Accepted Time:
2013-07-23 19:10:15
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1302573 Oncomed Pharmaceuticals Inc OMED Pharmaceutical Preparations (2834) 383572512
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1190636 M Steven Krausz 2735 Sand Hill Road
Menlo Park CA 94025
No No Yes No
1192391 Irwin Federman 2735 Sand Hill Road
Menlo Park CA 94025
No No Yes No
1212726 E David Liddle 2735 Sand Hill Road
Menlo Park CA 94025
No No Yes No
1225444 P L Viii Partners Venture Us 2735 Sand Hill Road
Menlo Park CA 94025
No No Yes No
1225446 P L A Viii Partners Entrepreneur Usvp 2735 Sand Hill Road
Menlo Park CA 94025
No No Yes No
1225448 P L B Viii Partners Entrepreneur Usvp 2735 Sand Hill Road
Menlo Park CA 94025
No No Yes No
1225449 P L Fund Affiliates Viii Usvp 2735 Sand Hill Road
Menlo Park CA 94025
No No Yes No
1225477 S Winston Fu 2735 Sand Hill Road
Menlo Park CA 94025
No No Yes No
1225484 C L L Viii Group Management Presidio 2735 Sand Hill Road
Menlo Park CA 94025
No No Yes No
1316575 J Christopher Rust 2735 Sand Hill Road
Menlo Park CA 94025
No No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2013-07-23 1,028,381 $0.00 1,028,381 No 4 C Indirect Directly owned by USVP VIII
Common Stock Acquisiton 2013-07-23 1,215,407 $0.00 2,243,788 No 4 C Indirect Directly owned by USVP VIII
Common Stock Acquisiton 2013-07-23 1,505,032 $0.00 3,748,820 No 4 C Indirect Directly owned by USVP VIII
Common Stock Acquisiton 2013-07-23 155,164 $17.00 3,903,984 No 4 P Indirect Directly owned by USVP VIII
Common Stock Acquisiton 2013-07-23 9,505 $0.00 9,505 No 4 C Indirect Directly owned by EP VIII-A
Common Stock Acquisiton 2013-07-23 11,233 $0.00 20,738 No 4 C Indirect Directly owned by EP VIII-A
Common Stock Acquisiton 2013-07-23 13,910 $0.00 34,648 No 4 C Indirect Directly owned by EP VIII-A
Common Stock Acquisiton 2013-07-23 1,434 $17.00 36,082 No 4 P Indirect Directly owned by EP VIII-A
Common Stock Acquisiton 2013-07-23 4,817 $0.00 4,817 No 4 C Indirect Directly owned by EP VIII-B
Common Stock Acquisiton 2013-07-23 5,694 $0.00 10,511 No 4 C Indirect Directly owned by EP VIII-B
Common Stock Acquisiton 2013-07-23 7,051 $0.00 17,562 No 4 C Indirect Directly owned by EP VIII-B
Common Stock Acquisiton 2013-07-23 727 $17.00 18,289 No 4 P Indirect Directly owned by EP VIII-B
Common Stock Acquisiton 2013-07-23 9,926 $0.00 9,926 No 4 C Indirect Directly owned by AFF VIII
Common Stock Acquisiton 2013-07-23 11,731 $0.00 21,657 No 4 C Indirect Directly owned by AFF VIII
Common Stock Acquisiton 2013-07-23 14,527 $0.00 36,184 No 4 C Indirect Directly owned by AFF VIII
Common Stock Acquisiton 2013-07-23 1,498 $17.00 37,682 No 4 P Indirect Directly owned by AFF VIII
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 C Indirect Directly owned by USVP VIII
No 4 C Indirect Directly owned by USVP VIII
No 4 C Indirect Directly owned by USVP VIII
No 4 P Indirect Directly owned by USVP VIII
No 4 C Indirect Directly owned by EP VIII-A
No 4 C Indirect Directly owned by EP VIII-A
No 4 C Indirect Directly owned by EP VIII-A
No 4 P Indirect Directly owned by EP VIII-A
No 4 C Indirect Directly owned by EP VIII-B
No 4 C Indirect Directly owned by EP VIII-B
No 4 C Indirect Directly owned by EP VIII-B
No 4 P Indirect Directly owned by EP VIII-B
No 4 C Indirect Directly owned by AFF VIII
No 4 C Indirect Directly owned by AFF VIII
No 4 C Indirect Directly owned by AFF VIII
No 4 P Indirect Directly owned by AFF VIII
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Series A Preferred Stock Disposition 2013-07-23 1,028,381 $0.00 1,028,381 $0.00
Common Stock Series A Preferred Stock Disposition 2013-07-23 9,505 $0.00 9,505 $0.00
Common Stock Series A Preferred Stock Disposition 2013-07-23 4,817 $0.00 4,817 $0.00
Common Stock Series A Preferred Stock Disposition 2013-07-23 9,926 $0.00 9,926 $0.00
Common Stock Series B Preferred Stock Disposition 2013-07-23 1,215,407 $0.00 1,215,407 $0.00
Common Stock Series B Preferred Stock Disposition 2013-07-23 11,233 $0.00 11,233 $0.00
Common Stock Series B Preferred Stock Disposition 2013-07-23 5,694 $0.00 5,694 $0.00
Common Stock Series B Preferred Stock Disposition 2013-07-23 11,731 $0.00 11,731 $0.00
Common Stock Series B-1 Preferred Stock Disposition 2013-07-23 1,505,032 $0.00 1,505,032 $0.00
Common Stock Series B-1 Preferred Stock Disposition 2013-07-23 13,910 $0.00 13,910 $0.00
Common Stock Series B-1 Preferred Stock Disposition 2013-07-23 7,051 $0.00 7,051 $0.00
Common Stock Series B-1 Preferred Stock Disposition 2013-07-23 14,527 $0.00 14,527 $0.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 No 4 C Indirect
0 No 4 C Indirect
0 No 4 C Indirect
0 No 4 C Indirect
0 No 4 C Indirect
0 No 4 C Indirect
0 No 4 C Indirect
0 No 4 C Indirect
0 No 4 C Indirect
0 No 4 C Indirect
0 No 4 C Indirect
0 No 4 C Indirect
Footnotes
  1. Each share of Series A, Series B and Series B-1 Preferred Stock automatically converted on a one-to-one basis into Common Stock immediately prior to the consummation of the Issuer's initial public offering on July 23, 2013.
  2. The reported securities are owned directly by each of U.S. Venture Partners VIII, L.P. ("USVP VIII"), USVP VIII Affiliates Fund, L.P. ("AFF VIII"), USVP Entrepreneur Partners VIII-A, L.P. ("EP VIII-A") and USVP Entrepreneur Partners VIII-B, L.P. ("EP VIII-B" and together with USVP VIII, AFF VIII and EP VIII-A, the "USVP Funds"). Presidio Management Group VIII, LLC, or PMG VIII, is the general partner of the USVP Funds, and may be deemed to have sole voting and dispositive power over the shares held by the USVP Funds. PMG VIII and Irwin Federman, Winston Fu, Steven Krausz, David Liddle, Jonathan Root, Christopher Rust, Casey Tansey and Philip Young, the managing members of PMG VII, who may be deemed to share voting and dispositive power over the reported securities, disclaim beneficial ownership of the reported securities held by the USVP Funds except to the extent of any pecuniary interest therein.
  3. The securities are immediately convertible.
  4. The expiration date is not relevant to the conversion of these securities.